CCN2 and breast carcinoma: Indeed, we noted that treatment of breast cancer cells with tryptase affected the chromatin accessibility in several regions, including reduced chromatin accessibility in regions containing genes whose transcription were suppressed by tryptase (e.g., CCN1, CCN2).